Grant/GrossMendelsohn »

Eyepoint Pharmaceuticals shares owned by Grant/GrossMendelsohn

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Grant/GrossMendelsohn from 13F filings

Historical chart of Grant/GrossMendelsohn investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Grant/GrossMendelsohn consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Grant/GrossMendelsohn

Quarter filed Position value Share count Share price at filing
2025-03-31 $248k 37k 6.78
2024-12-31 $273k 37k 7.45
2024-09-30 $293k 37k 7.99

More positions owned by Grant/GrossMendelsohn

Ishares Tr TRS FLT RT BD (TFLO)
Spdr Gold Tr Gold Shs (GLD)
T Rowe Price Etf Cap Appreciation (TCAF)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Oracle Corporation (ORCL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Ishares Tr Core Us Aggbd Et (AGG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Fidelity Covington Trust Msci Utils Index (FUTY)
Apple (AAPL)
Fidelity Covington Trust Consmr Staples (FSTA)
Fidelity Covington Trust Msci Hlth Care I (FHLC)
Microsoft Corporation (MSFT)

View all positions for Grant/GrossMendelsohn

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
Adage Capital Partners GP
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
TCG Crossover Management
Citadel Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Geode Capital Management
Goldman Sachs Group
State Street Corporation
Essex Woodlands Health Ventures

View all funds holding Eyepoint Pharmaceuticals